molecular-psychiatry
Molecular Psychiatry (molecular-psychiatry)
Journal positioning
Molecular Psychiatry, published by Springer Nature, is a leading journal in biological psychiatry and translational neuroscience, focusing on the molecular, genetic, cellular, and circuit mechanisms underlying psychiatric disorders and their interface with clinical phenomena. It occupies the space between basic neuroscience journals and clinical psychiatry journals, demanding both mechanistic depth and clear translational or clinical relevance. The readership spans psychiatric genetics researchers, translational neuroscientists, clinical researchers, and psychiatrists interested in biological mechanisms, so a paper must articulate both the mechanism and its disease relevance. This skill is a fit / venue-selection / re-framing tool. It does not replace the journal's current official submission guidelines. Before submitting, re-check the live author instructions on nature.com/mp.
When to trigger
- The author names Molecular Psychiatry or Mol Psychiatry as the target venue.
- A psychiatric genetics, neuroimaging genetics, or mechanistic psychiatry study has both biological depth and patient-relevant findings.
- A translational neuroscience manuscript in depression, schizophrenia, bipolar disorder, autism, OCD, or addiction needs venue calibration at this tier.
- The author needs Molecular Psychiatry's desk-reject risks, significance bar, and a credible re-routing within biological psychiatry.